Insider Transactions

Print Print page     Email Email page

Date Name Title Type Shares Traded Sorted Ascending Price Range
Mar 12, 2008 burge daniel j Officer Statement of Ownership 0 n/a
Oct 17, 2006 clark edward a Beneficial Owner (10% or more) Statement of Ownership 0 n/a
Sep 1, 2009 facet biotech corp Beneficial Owner (10% or more) Statement of Ownership 0 n/a
Oct 17, 2006 Fhm III, Llc Beneficial Owner (10% or more) Statement of Ownership 0 n/a
Mar 12, 2008 mckereghan kathleen Officer Statement of Ownership 0 n/a
Mar 12, 2008 mohler kendall Officer Statement of Ownership 0 n/a
Mar 10, 2009 stromatt scott Officer Statement of Ownership 0 n/a
Oct 23, 2006 Vef Management IV, Llc Beneficial Owner (10% or more) Buy 704 13.00
Oct 23, 2006 Venrock Entrepreneurs Fund IV, L.p. Beneficial Owner (10% or more) Buy 704 13.00
Sep 3, 2008 mann david a Director Buy 1,000 4.15
Oct 18, 2006 thompson peter a Officer Buy 1,000 13.00
Sep 4, 2008 mann david a Director Buy 1,400 4.20
Sep 5, 2008 mann david a Director Buy 1,600 4.27
Dec 1, 2006 mann david a Director Buy 1,935 18.35 - 18.88
Nov 29, 2006 mann david a Director Buy 3,000 18.50
Nov 20, 2007 mann david a Director Buy 4,000 10.00
Nov 19, 2007 thompson peter a Officer Buy 5,000 9.84 - 10.13
Oct 23, 2006 Venrock Partners Management, llc Beneficial Owner (10% or more) Buy 5,840 13.00
Oct 23, 2006 Venrock Partners, L.p. Beneficial Owner (10% or more) Buy 5,840 13.00
Oct 23, 2006 Venrock Associates IV, L.p. Beneficial Owner (10% or more) Buy 28,637 13.00
Showing 1-20 of 44 transactions Page: 1 2 3  See Next 20

Stock transaction information provided by EDGAR Online. Trubion Pharmaceuticals, Inc. makes no representations or warranties with respect to the information contained herein and takes no responsibility for supplementing, updating, or correcting any such information. This listing does not include non-monetary transactions, such as stock option grants or shares purchased through the employee stock purchase plan. For recent transactions including non-monetary transactions, see our Section 16 SEC filings page.